BioCentury
ARTICLE | Financial News

Pathway Genomics raises $40M

January 6, 2016 2:08 AM UTC

Pathway Genomics Corp. (San Diego, Calif.) said it raised more than $40 million in a series E round from investors including the IBM Watson unit of IBM Corp. (NYSE: IBM). Pathway said it expects to complete the round this quarter with additional investments. The company did not respond to inquiries.

IBM Watson and Pathway are developing a mobile app designed to provide users with personalized health information based on health history. ...